Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Co-Diagnostics Inc (NQ: CODX ) 1.620 -0.130 (-7.42%) Streaming Delayed Price Updated: 1:22 PM EDT, Aug 26, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Co-Diagnostics Inc < Previous 1 2 3 4 5 Next > CODX Stock Earnings: Co-Diagnostics Beats EPS, Beats Revenue for Q2 2024 August 08, 2024 CODX stock results show that Co-Diagnostics beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. Via InvestorPlace 12 Health Care Stocks Moving In Monday's Pre-Market Session June 10, 2024 Via Benzinga Why G-III Apparel Shares Are Trading Lower By 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session June 06, 2024 Via Benzinga Peering Into Co-Diagnostics's Recent Short Interest April 02, 2024 Via Benzinga Co-Diagnostics: Q4 Earnings Insights March 14, 2024 Via Benzinga Earnings Preview: Co-Diagnostics March 13, 2024 Via Benzinga 12 Health Care Stocks Moving In Thursday's Intraday Session June 06, 2024 Via Benzinga CODX Stock Earnings: Co-Diagnostics Misses EPS, Misses Revenue for Q1 2024 May 09, 2024 CODX stock results show that Co-Diagnostics missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024. Via InvestorPlace CODX Stock Earnings: Co-Diagnostics Misses EPS, Misses Revenue for Q4 2023 March 14, 2024 CODX stock results show that Co-Diagnostics missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of 2023. Via InvestorPlace 12 Health Care Stocks Moving In Friday's After-Market Session November 10, 2023 Via Benzinga Biden Administration Restarts Distribution Of Free At Home COVID-19 Tests, After Suspending For Year September 21, 2023 In response to the escalating spread of the virus nationwide, the Biden administration declared that it would recommence offering free at-home COVID tests to American households starting next Monday. Via Benzinga Exposures COVID-19 Preview: Co-Diagnostics's Earnings May 10, 2023 Via Benzinga Earnings Scheduled For March 14, 2024 March 14, 2024 Companies Reporting Before The Bell • Pharming (NASDAQ:PHAR) is projected to report earnings for its fourth quarter. Via Benzinga Co-Diagnostics Earnings Perspective: Return On Invested Capital March 17, 2023 Via Benzinga Preview: Co-Diagnostics's Earnings March 15, 2023 Via Benzinga 7 Doomed Growth Stocks Destined for Disaster July 12, 2023 Investing in growth stocks can be very expensive. Save yourself some time and money by avoiding these doomed growth stocks to sell. Via InvestorPlace Spectrum Brands, Sanmina And 3 Stocks To Watch Heading Into Friday May 12, 2023 With US stock futures trading higher this morning on Friday, some of the stocks that may grab investor focus today are as follows: Via Benzinga 12 Health Care Stocks Moving In Wednesday's Pre-Market Session March 08, 2023 Via Benzinga Co-Diagnostics's Earnings Outlook November 09, 2022 Co-Diagnostics (NASDAQ:CODX) is set to give its latest quarterly earnings report on Thursday, 2022-11-10. Here's what investors need to know before the announcement. Analysts estimate that... Via Benzinga FDA To Review Smaller Number Of Emergency Use Requests For COVID-19 Tests September 27, 2022 Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For March 20, 2023 March 20, 2023 Via Benzinga 7 Vaccine Stocks to Sell ASAP Now That the ‘Pandemic’s Over’ September 27, 2022 Investors have seven widely-followed vaccine stocks to sell now, after the world decided the pandemic is over. Via InvestorPlace COVID-19 Complacency Pushes Identification Of New Variants To Back Seat, WHO Warns September 23, 2022 The World Health Organization (WHO) warned that it struggles to identify and Via Benzinga Co-Diagnostics's Return On Capital Employed Overview September 07, 2022 Benzinga Pro data, Co-Diagnostics (NASDAQ:CODX) reported Q2 sales of $5.02 million. Earnings fell to a loss of $2.69 million, resulting in a 122.93% decrease from last quarter. Via Benzinga No More Free COVID-19 At-Home Tests, Federal Government Says August 29, 2022 CNBC reported that the federal government is set to suspend its offer of free at-home COVID-19 tests by Friday, September 2, without congressional au Via Benzinga Mizuho Increases PT On ON Semiconductor, Charter Communications Price Target Cut By 37% August 15, 2022 Atlantic Equities lowered the price target on Charter Communications, Inc. (NASDAQ: CHTR) from $755 to $477. Charter Communications shares fell 1.7% to $470.00 in pre-market trading. Via Benzinga This Analyst Boosts Price Target On Dillard's; Also Check Out Some Other Big PT Changes August 15, 2022 JP Morgan raised the price target for Dillard's, Inc. (NYSE: DDS) from $210 to $298. Dillard's shares rose 0.9% to $304.42 in pre-market trading. Via Benzinga Stocks That Hit 52-Week Lows On Thursday August 18, 2022 During Thursday's trading, 62 companies set new 52-week lows. Via Benzinga Illumina, Poshmark, Olo And Some Other Big Losers From Friday August 15, 2022 U.S. stocks closed higher on Friday, with the Dow Jones gaining more than 400 points. Here is the list of some big stocks moving lower in the previous session. Via Benzinga Why Embark Technology Jumped Around 85%; Here Are 108 Biggest Movers From Friday August 15, 2022 Gainers Embark Technology, Inc. (NASDAQ: EMBK) jumped 84.8% to close at $1.07 on Friday after the company reported better-than-expected Q2 EPS results. Via Benzinga < Previous 1 2 3 4 5 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.